 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 1481 | 回復(fù): 7 | |||
| 當(dāng)前只顯示滿足指定條件的回帖，點擊這里查看本話題的所有回帖 | |||
luwangxing金蟲 (正式寫手)
|
[交流]
【轉(zhuǎn)帖】國產(chǎn)PVP遭遇FDA發(fā)難，過氧化物超標(biāo) 已有5人參與
|
||
|
原文：http://www.fda.gov/drugs/drugsafety/ucm230492.htm 博愛新開源算是國內(nèi)PVP較為主要的供應(yīng)商吧 過氧化物超標(biāo)4倍 CP05，和CP10沒有檢查該項目 Advisory to Drug and Dietary Supplement Manufacturers, Compounding Pharmacies and Distributors of Excipients and Dietary Ingredients – FDA Detects High Levels of Peroxide in Crospovidone [10-21-2010] The U.S. Food and Drug Administration is alerting drug and dietary supplement manufacturers, compounding pharmacies, and distributors of Povidone analogs (Povidone/Copovidone/Crospovidone), that the agency recently detected excessive levels of peroxide in one lot of Crospovidone (cross linked polyvinyl N-pyrrolidone) manufactured by China-based Tianjin Boai NKY International Ltd1. The peroxide level found by the FDA in the lot was more than four (4) times the maximum level of peroxide (400 ppm) allowed by global compendial monographs. Other lots of Povidone analogs2 manufactured by this firm may also contain excessive levels of peroxide. An Import Alert has been issued to prevent further entry of Tianjin Boai NKY International Ltd Crospovidone into the U.S. market. To date, the FDA is not aware of any illnesses in the United States stemming from peroxide contamination. The level of peroxide found in this particular lot does not appear, on its own, to pose a significant health risk in drugs or dietary supplements. The FDA nonetheless remains concerned that elevated levels of peroxide can cause subpotent finished products. Crospovidone is a very common ingredient in drugs and dietary supplements. Peroxide is a potential impurity from the polymerization step involved in the manufacturing of Povidone analogs. Residual peroxide levels of <100 ppm have been reported to cause oxidative degradation.3 The FDA is concerned that drug manufacturers using excipients containing high levels of peroxides will observe a loss of drug potency and the formation of excessive impurities during the product shelf life. It is essential that users and distributors implement robust supplier management programs to assure that peroxide levels in Povidone analogs are in control for each batch received. Manufacturers using such excipients should employ sound risk management principles in establishing appropriate scrutiny (including peroxide testing regimen) and actions to take for a given supplier, including but not limited to the following: ( a ) review supplier history, including any relevant information on manufacturing reliability; ( b ) assess peroxide levels obtained from testing4 of past batches of Povidone analogs; ( c ) determine reliability of results reported on Certificates of Analysis; ( d ) consider information obtained from ongoing communications with suppliers; and ( e ) determine whether the quality of any finished product has been impacted. Manufacturers who use ingredients that might contain elevated levels of peroxide are advised to notify the FDA if they become aware of any further findings of quality problems or potentially related adverse events. 1 May also do business as Friends Union Enterprise (Jianjin) Ltd, Boai New Kaiyuan Pharmaceutical Company, Boai NKY Pharmaceuticals Ltd or Bluetech Chemicals Limited. 2 A recently published study also found elevated levels of peroxide in multiple lots of Povidone analogs, consistent with the FDA’s findings. (Silverstein, PhD, Irwin, Pharmaceutical Technology, Vol. 33, Issue 10, pp. 84-88, October 02, 2009. “The Case for Supplier Qualification.”) 3 Hartauer, et al, Pharm. Dev. Technol. 2000;5(3):303-10. “Influence of peroxide impurities in povidone and crospovidone on the stability of raloxifene hydrochloride in tablets: identification and control of an oxidative degradation product.” 4 A peroxide test is not currently listed in the USP monographs for crospovidone and povidone. However, a non-specific USP/EP method (see Copovidone NF) can be used to readily detect peroxide present at 400 ppm in Povidone analogs. Alternatively, a validated method shown to be specific for peroxide and having at least the same sensitivity as the compendial method may be used. For import alert information, please see: http://www.accessdata.fda.gov/cms_ia/importalert_189.html 這是我在sfda網(wǎng)站看到的。據(jù)我所知，巴斯夫的交聯(lián)吡咯烷酮的COA中有這一項指標(biāo)，標(biāo)準是不大于400ppm。 |
回復(fù)此樓» 猜你喜歡
085600 286分 材料求調(diào)劑
已經(jīng)有11人回復(fù)
-
一志愿河北工業(yè)大學(xué)0817化工278分求調(diào)劑
已經(jīng)有15人回復(fù)
-
085601材料工程找調(diào)劑
已經(jīng)有15人回復(fù)
-
材料與化工272求調(diào)劑
已經(jīng)有15人回復(fù)
-
南京大學(xué)化學(xué)調(diào)劑
已經(jīng)有14人回復(fù)
-
一志愿北京工業(yè)大學(xué)，324分求調(diào)劑
已經(jīng)有6人回復(fù)
-
求調(diào)劑
已經(jīng)有5人回復(fù)
-
281求調(diào)劑
已經(jīng)有6人回復(fù)
-
26申博自薦
已經(jīng)有6人回復(fù)
-
一志愿哈爾濱工業(yè)大學(xué)材料與化工方向336分
已經(jīng)有10人回復(fù)
» 本主題相關(guān)價值貼推薦，對您同樣有幫助:
- 轉(zhuǎn)：具有全新降低血糖機制的新藥被fda專家小組否定
已經(jīng)有3人回復(fù)
tjegg
鐵桿木蟲 (著名寫手)
- 應(yīng)助: 26 (小學(xué)生)
- 金幣: 6869.3
- 紅花: 16
- 帖子: 2615
- 在線: 448小時
- 蟲號: 338983
- 注冊: 2007-04-05
- 性別: GG
- 專業(yè): 抗腫瘤藥物藥理
4樓2010-10-26 15:04:13
tjegg
鐵桿木蟲 (著名寫手)
- 應(yīng)助: 26 (小學(xué)生)
- 金幣: 6869.3
- 紅花: 16
- 帖子: 2615
- 在線: 448小時
- 蟲號: 338983
- 注冊: 2007-04-05
- 性別: GG
- 專業(yè): 抗腫瘤藥物藥理
2樓2010-10-26 10:31:59
reallove2935
禁言 (著名寫手)
★
小木蟲(金幣+0.5):給個紅包，謝謝回帖交流
小木蟲(金幣+0.5):給個紅包，謝謝回帖交流
|
本帖內(nèi)容被屏蔽 |
3樓2010-10-26 14:03:00
meteord
木蟲 (正式寫手)
- 應(yīng)助: 17 (小學(xué)生)
- 金幣: 5330.2
- 散金: 68
- 紅花: 1
- 帖子: 436
- 在線: 192.9小時
- 蟲號: 862641
- 注冊: 2009-10-04
- 性別: GG
- 專業(yè): 藥劑學(xué)
7樓2010-10-28 09:15:57
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 南京大學(xué)化學(xué)調(diào)劑 +9 | 景隨風(fēng) 2026-03-29 | 14/700 |
|
|---|---|---|---|---|
|
[考研] 275求調(diào)劑 +15 | Micky11223 2026-03-25 | 20/1000 |
|
|
|
[考研] 299求調(diào)劑 +10 | 15188958825 2026-03-25 | 10/500 |
|
|
|
[考研] 本科新能源科學(xué)與工程，一志愿華理能動285求調(diào)劑 +7 | AZMK 2026-03-28 | 11/550 |
|
|
|
[考研] 調(diào)劑 +3 | 好好讀書。 2026-03-28 | 3/150 |
|
|
|
[材料工程] 一志愿C9材料與化工專業(yè)總分300求調(diào)劑 +8 | 曼111 2026-03-24 | 9/450 |
|
|
|
[考研] 070300化學(xué)求調(diào)劑 +4 | 起個名咋這么難 2026-03-27 | 4/200 |
|
|
|
[考研] 一志愿上海理工能源動力（085800）310分求調(diào)劑 +3 | zhangmingc 2026-03-27 | 4/200 |
|
|
|
[考研] 274求調(diào)劑 +17 | 顧九笙要謙虛 2026-03-24 | 23/1150 |
|
|
|
[考研] 316求調(diào)劑 +5 | Pigcasso 2026-03-24 | 5/250 |
|
|
|
[考研] 調(diào)劑 +3 | 李嘉圖·S·路 2026-03-27 | 3/150 |
|
|
|
[考研] 材料調(diào)劑 +8 | 匹克i 2026-03-23 | 8/400 |
|
|
|
[考研] 324求調(diào)劑 +8 | hanamiko 2026-03-26 | 10/500 |
|
|
|
[考研] 085601求調(diào)劑總分293英一數(shù)二 +4 | 鋼鐵大炮 2026-03-24 | 4/200 |
|
|
|
[考研] 打過很多競賽，085406控制工程300分，求調(diào)劑 +3 | askeladz 2026-03-26 | 3/150 |
|
|
|
[考研] 296求調(diào)劑 +4 | 汪！？！ 2026-03-25 | 7/350 |
|
|
|
[考研] 各位老師您好：本人初試372分 +5 | jj涌77 2026-03-25 | 6/300 |
|
|
|
[考研] 上海電力大學(xué)材料防護與新材料重點實驗室招收調(diào)劑研究生（材料、化學(xué)、電化學(xué)，環(huán)境） +4 | 我愛學(xué)電池 2026-03-23 | 4/200 |
|
|
|
[考研] 化工專碩求調(diào)劑 +3 | question挽風(fēng) 2026-03-24 | 3/150 |
|
|
|
[考研]
 材料考研調(diào)劑生
+3
|
黃粱一夢千年 2026-03-24 | 3/150 |
|